EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly

E E Sakhnova, E G Przhiyalkovskaya, Zh E Belaya, G A Melnichenko

Problems of Endocrinology · 17.12.2021 · 68 (1) · 40-48

DOI: 10.14341/probl12791 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Problems of Endocrinology, online erschienen am 17.12.2021. Verfasst von E E Sakhnova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre. Hauptthemen laut MEDLINE: Acromegaly, Human Growth Hormone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acromegaly is a rare endocrine disorder associated with multiple complications and increased mortality. Timely diagnosis and adequate treatment can bring the life expectancy of patients with acromegaly closer to the general population level. The tests for the diagnosis of acromegaly are measurement of both serum GH, and GH after oral glucose administration; serum insulin-like growth factor-1 (IGF-1). However, in clinical practice, up to 39% of patients with discordant results are found. The patients with discordant GH and IGF-1levels, are the most difficult to manage. This review discusses the prevalence of discordant GH and IGF-1 outcomes in patients with acromegaly; factors causing this discrepancy; the impact of hormone levels on treatment outcomes. Although endocrinologists are used to dealing with this discrepancy in clinical practice for many years, discordant patients’outcome remains uncertain and undefined The optimal treatment should be individually tailored for each patient, taking into account all clinical parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyHuman Growth HormoneGrowth HormoneHumansInsulin-Like Growth Factor ITreatment Outcome

Substanzen

Human Growth HormoneInsulin-Like Growth Factor IGrowth Hormone

Autor:innen und Institutionen

  • Endocrinology Research Centre.

Zitieren

APA

Sakhnova, E. E., Przhiyalkovskaya, E. G., Belaya, Z. E., & Melnichenko, G. A. (2021). Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly. Problems of Endocrinology, 68(1), 40-48. https://doi.org/10.14341/probl12791

Vancouver

Sakhnova EE, Przhiyalkovskaya EG, Belaya ZE, Melnichenko GA. Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly. Problems of Endocrinology. 2021;68(1):40-48. doi:10.14341/probl12791

BibTeX
@article{Sakhnova2021,
  author = {Sakhnova, E E and Przhiyalkovskaya, E G and Belaya, Zh E and Melnichenko, G A},
  title = {Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly},
  journal = {Problems of Endocrinology},
  year = {2021},
  volume = {68},
  number = {1},
  pages = {40--48},
  doi = {10.14341/probl12791}
}
Kostenlos starten →